Stories
Natco Pharma Approves ₹1,279 Crore Rights Issue: Dates, Price, Entitlement Revealed!
C
CNBC TV18•25-09-2026, 12:04
Natco Pharma Approves ₹1,279 Crore Rights Issue: Dates, Price, Entitlement Revealed!
- •Natco Pharma Ltd. approved raising up to ₹1,279 crore through a rights issue at ₹750 per share, an 11% discount from its current market price.
- •The company will issue 1.7 crore rights equity shares, with the record date set for Thursday, October 1, 2026.
- •Eligible shareholders will receive two rights shares for every 21 shares held as of the record date.
- •The rights issue opens for subscription on Monday, October 12, and closes on October 22, 2026.
- •On-market renunciation of shares will occur between October 12 and October 16, 2026, allowing shareholders to sell their rights entitlement.
Key Questions Answered
Natco Pharma has approved raising up to ₹1,279 crore through a rights issue by issuing 1.7 crore equity shares. The price has been fixed at ₹750 per share, which is an 11% discount from the company's current market price.
The record date for the rights issue is Thursday, October 1, 2026, meaning shareholders must own shares by September 30. The subscription window opens on October 12, 2026, and closes on October 22, 2026.
Eligible shareholders of Natco Pharma are entitled to receive two rights shares for every 21 shares held as of the record date.
